Ophthalmic delivery device and ophthalmic drug compositions
US11622884B2 · kind B2 · utility
2Cited by
12References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2017 |
| Grant date | Apr 11, 2023 |
| Priority date | — |
| Expiry date | Jul 5, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a cannulation device for administering an active agent containing composition to the suprachoroidal space or supraciliary space. The invention provides methods of treatment of an ocular disease or condition accordingly. The invention also provides compositions for use in a method of treatment of an ocular disease or condition for delivery into the suprachoroidal space or supraciliary space.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.